JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

IDEXX Laboratories Inc

Geschlossen

BrancheGesundheitswesen

651.63 -1.04

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

646.53

Max

664.77

Schlüsselkennzahlen

By Trading Economics

Einkommen

27M

243M

Verkäufe

44M

998M

KGV

Branchendurchschnitt

49.513

34.393

EPS

3.5

Gewinnspanne

24.306

Angestellte

11,000

EBITDA

54M

352M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+10.21% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

30. Okt. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

17B

55B

Vorheriger Eröffnungskurs

652.67

Vorheriger Schlusskurs

651.63

Nachrichtenstimmung

By Acuity

50%

50%

162 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

IDEXX Laboratories Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

4. Aug. 2025, 11:15 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Palantir, Tesla, Berkshire Hathaway, ON Semiconductor, Amazon, Boeing, and More -- Barrons.com

Peer-Vergleich

Kursveränderung

IDEXX Laboratories Inc Prognose

Kursziel

By TipRanks

10.21% Vorteil

12-Monats-Prognose

Durchschnitt 725.22 USD  10.21%

Hoch 785 USD

Tief 640 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für IDEXX Laboratories Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

10 ratings

6

Buy

3

Halten

1

Sell

Technischer Score

By Trading Central

440.98 / N/AUnterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Strong Bullish Evidence

Langfristig

Weak Bullish Evidence

Stimmung

By Acuity

162 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über IDEXX Laboratories Inc

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.